279 related articles for article (PubMed ID: 36819091)
1. Neutrophil extracellular traps (NETs)-related lncRNAs signature for predicting prognosis and the immune microenvironment in breast cancer.
Jiang T; Wang Y; Chen X; Xia W; Xue S; Gu L; Guo L; Lin H
Front Cell Dev Biol; 2023; 11():1117637. PubMed ID: 36819091
[No Abstract] [Full Text] [Related]
2. A neutrophil extracellular traps-associated lncRNA signature predicts the clinical outcomes in patients with lung adenocarcinoma.
Ding W; Li B; Zhang Y; He L; Su J
Front Genet; 2022; 13():1047231. PubMed ID: 36419832
[No Abstract] [Full Text] [Related]
3. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
Cao J; Liang Y; Gu JJ; Huang Y; Wang B
Front Genet; 2022; 13():991162. PubMed ID: 36353118
[No Abstract] [Full Text] [Related]
4. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer.
Cai J; Ji Z; Wu J; Chen L; Zheng D; Chen Y; Zhang X; Xie W; Huang J; Chen M; Lin R; Lin W; Chen Y; Li Z
Front Genet; 2022; 13():949314. PubMed ID: 36092873
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients.
Jiang ZR; Yang LH; Jin LZ; Yi LM; Bing PP; Zhou J; Yang JS
Front Oncol; 2022; 12():988680. PubMed ID: 36203428
[TBL] [Abstract][Full Text] [Related]
7. A innovative prognostic symbol based on neutrophil extracellular traps (NETs)-related lncRNA signature in non-small-cell lung cancer.
Fang C; Liu F; Wang Y; Yuan S; Chen R; Qiu X; Qian X; Zhang X; Xiao Z; Wang Q; Fu B; Li Y
Aging (Albany NY); 2021 Jul; 13(13):17864-17879. PubMed ID: 34257164
[TBL] [Abstract][Full Text] [Related]
8. The metabolism-related lncRNA signature predicts the prognosis of breast cancer patients.
Ge X; Lei S; Wang P; Wang W; Wang W
Sci Rep; 2024 Feb; 14(1):3500. PubMed ID: 38347041
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of endocrine resistance-related and immune-related long non-coding RNA (lncRNA) signatures for predicting endocrinotherapy response and prognosis in breast cancer.
Yang M; Sun Y; Ji H; Zhang Q
Ann Transl Med; 2022 Dec; 10(24):1399. PubMed ID: 36660659
[TBL] [Abstract][Full Text] [Related]
10. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
Front Oncol; 2022; 12():876660. PubMed ID: 35747790
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of Ferroptosis-Related LncRNAs in Breast Cancer Patients Reveals Prognostic Value and Relationship With Tumor Immune Microenvironment.
Xu Z; Jiang S; Ma J; Tang D; Yan C; Fang K
Front Surg; 2021; 8():742360. PubMed ID: 34671639
[No Abstract] [Full Text] [Related]
12. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
13. A Novel Aging-Related Prognostic lncRNA Signature Correlated with Immune Cell Infiltration and Response to Immunotherapy in Breast Cancer.
Liu Z; Ren C; Cai J; Yin B; Yuan J; Ding R; Ming W; Sun Y; Li Y
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110517
[TBL] [Abstract][Full Text] [Related]
14. A prognostic risk prediction model based on ferroptosis-related long non-coding RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation.
Xiang X; Guo Y; Chen Z; Zhang F; Huang J; Qin Y
Medicine (Baltimore); 2022 Dec; 101(51):e32558. PubMed ID: 36595859
[TBL] [Abstract][Full Text] [Related]
15. Pyroptosis-Related lncRNAs Predict the Prognosis and Immune Response in Patients With Breast Cancer.
Yang X; Weng X; Yang Y; Jiang Z
Front Genet; 2021; 12():792106. PubMed ID: 35360412
[No Abstract] [Full Text] [Related]
16. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
He Y; Ye Y; Tian W; Qiu H
Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
[No Abstract] [Full Text] [Related]
17. A Neutrophil Extracellular Traps Signature Predicts the Clinical Outcomes and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.
Chen N; He D; Cui J
Front Mol Biosci; 2022; 9():833771. PubMed ID: 35252353
[No Abstract] [Full Text] [Related]
18. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer.
Ping L; Zhang K; Ou X; Qiu X; Xiao X
Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734
[No Abstract] [Full Text] [Related]
19. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma.
Wang L; Ge X; Zhang Z; Ye Y; Zhou Z; Li M; Yan H; Wu L; Bai Q; Li J; Zhu J; Wang Y
Front Genet; 2021; 12():682082. PubMed ID: 34745200
[No Abstract] [Full Text] [Related]
20. Impact of Long Non-coding RNAs Associated With Microenvironment on Survival for Bladder Cancer Patients.
Lin G; Guo B; Wei Y; Lan T; Wen S; Li G
Front Genet; 2020; 11():567200. PubMed ID: 33281872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
